vs

Side-by-side financial comparison of LESAKA TECHNOLOGIES INC (LSAK) and Tilray Brands, Inc. (TLRY). Click either name above to swap in a different company.

Tilray Brands, Inc. is the larger business by last-quarter revenue ($217.5M vs $178.7M, roughly 1.2× LESAKA TECHNOLOGIES INC). LESAKA TECHNOLOGIES INC runs the higher net margin — 2.0% vs -20.7%, a 22.7% gap on every dollar of revenue. On growth, Tilray Brands, Inc. posted the faster year-over-year revenue change (3.1% vs 1.4%). Over the past eight quarters, LESAKA TECHNOLOGIES INC's revenue compounded faster (13.7% CAGR vs 7.5%).

Lesaka Technologies is a South-African financial technology company that is listed on the NASDAQ and Johannesburg Stock Exchange. Lesaka’s primary focus is on financial inclusion, offering financial services to previously underserved communities and merchants.

Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.

LSAK vs TLRY — Head-to-Head

Bigger by revenue
TLRY
TLRY
1.2× larger
TLRY
$217.5M
$178.7M
LSAK
Growing faster (revenue YoY)
TLRY
TLRY
+1.7% gap
TLRY
3.1%
1.4%
LSAK
Higher net margin
LSAK
LSAK
22.7% more per $
LSAK
2.0%
-20.7%
TLRY
Faster 2-yr revenue CAGR
LSAK
LSAK
Annualised
LSAK
13.7%
7.5%
TLRY

Income Statement — Q2 FY2026 vs Q2 FY2026

Metric
LSAK
LSAK
TLRY
TLRY
Revenue
$178.7M
$217.5M
Net Profit
$3.6M
$-44.9M
Gross Margin
31.4%
26.4%
Operating Margin
1.2%
-10.2%
Net Margin
2.0%
-20.7%
Revenue YoY
1.4%
3.1%
Net Profit YoY
111.2%
47.4%
EPS (diluted)
$0.04
$-0.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LSAK
LSAK
TLRY
TLRY
Q4 25
$178.7M
$217.5M
Q3 25
$171.4M
$209.5M
Q2 25
$168.5M
$224.5M
Q1 25
$161.4M
$185.8M
Q4 24
$176.2M
$210.9M
Q3 24
$153.6M
$200.0M
Q2 24
$146.0M
$229.9M
Q1 24
$138.2M
$188.3M
Net Profit
LSAK
LSAK
TLRY
TLRY
Q4 25
$3.6M
$-44.9M
Q3 25
$-4.3M
$-322.0K
Q2 25
$-28.4M
$-1.3B
Q1 25
$-22.1M
$-789.4M
Q4 24
$-32.5M
$-85.3M
Q3 24
$-4.5M
$-39.2M
Q2 24
$-5.0M
$-31.7M
Q1 24
$-4.0M
$-92.7M
Gross Margin
LSAK
LSAK
TLRY
TLRY
Q4 25
31.4%
26.4%
Q3 25
30.9%
27.4%
Q2 25
28.9%
30.1%
Q1 25
27.5%
28.0%
Q4 24
25.7%
29.0%
Q3 24
22.6%
29.8%
Q2 24
22.6%
35.8%
Q1 24
22.0%
26.2%
Operating Margin
LSAK
LSAK
TLRY
TLRY
Q4 25
1.2%
-10.2%
Q3 25
0.2%
1.0%
Q2 25
-16.7%
-643.1%
Q1 25
0.4%
-409.0%
Q4 24
0.3%
-20.0%
Q3 24
-0.0%
-18.3%
Q2 24
0.2%
-7.2%
Q1 24
0.6%
-43.6%
Net Margin
LSAK
LSAK
TLRY
TLRY
Q4 25
2.0%
-20.7%
Q3 25
-2.5%
-0.2%
Q2 25
-16.9%
-566.9%
Q1 25
-13.7%
-424.9%
Q4 24
-18.4%
-40.5%
Q3 24
-3.0%
-19.6%
Q2 24
-3.4%
-13.8%
Q1 24
-2.9%
-49.2%
EPS (diluted)
LSAK
LSAK
TLRY
TLRY
Q4 25
$0.04
$-0.41
Q3 25
$-0.05
$0.00
Q2 25
$-0.40
$7.26
Q1 25
$-0.27
$-8.69
Q4 24
$-0.40
$-0.99
Q3 24
$-0.07
$-0.04
Q2 24
$-0.08
$-0.04
Q1 24
$-0.06
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LSAK
LSAK
TLRY
TLRY
Cash + ST InvestmentsLiquidity on hand
$69.5M
$291.6M
Total DebtLower is stronger
$216.8M
Stockholders' EquityBook value
$180.6M
$1.6B
Total Assets
$704.6M
$2.1B
Debt / EquityLower = less leverage
1.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LSAK
LSAK
TLRY
TLRY
Q4 25
$69.5M
$291.6M
Q3 25
$72.2M
$264.8M
Q2 25
$76.5M
$256.4M
Q1 25
$71.0M
Q4 24
$60.6M
$252.2M
Q3 24
$49.7M
$280.1M
Q2 24
$59.1M
$260.5M
Q1 24
$55.2M
$225.9M
Total Debt
LSAK
LSAK
TLRY
TLRY
Q4 25
$216.8M
Q3 25
$208.1M
Q2 25
$200.8M
Q1 25
$194.7M
Q4 24
$148.7M
Q3 24
$148.5M
Q2 24
$143.2M
Q1 24
$135.7M
Stockholders' Equity
LSAK
LSAK
TLRY
TLRY
Q4 25
$180.6M
$1.6B
Q3 25
$170.4M
$1.5B
Q2 25
$161.6M
$1.5B
Q1 25
$185.2M
$2.7B
Q4 24
$193.3M
$3.5B
Q3 24
$184.2M
$3.5B
Q2 24
$175.9M
$3.4B
Q1 24
$173.1M
$3.4B
Total Assets
LSAK
LSAK
TLRY
TLRY
Q4 25
$704.6M
$2.1B
Q3 25
$652.9M
$2.1B
Q2 25
$653.7M
$2.1B
Q1 25
$649.2M
Q4 24
$640.6M
$4.2B
Q3 24
$551.9M
$4.3B
Q2 24
$558.5M
$4.2B
Q1 24
$551.5M
$4.2B
Debt / Equity
LSAK
LSAK
TLRY
TLRY
Q4 25
1.20×
Q3 25
1.22×
Q2 25
1.24×
Q1 25
1.05×
Q4 24
0.77×
Q3 24
0.81×
Q2 24
0.81×
Q1 24
0.78×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LSAK
LSAK
TLRY
TLRY
Operating Cash FlowLast quarter
$-10.9M
$-8.5M
Free Cash FlowOCF − Capex
$-14.8M
FCF MarginFCF / Revenue
-8.3%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
-2.99×
TTM Free Cash FlowTrailing 4 quarters
$-15.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LSAK
LSAK
TLRY
TLRY
Q4 25
$-10.9M
$-8.5M
Q3 25
$8.9M
$-1.3M
Q2 25
$-9.1M
$-12.8M
Q1 25
$10.7M
$-5.8M
Q4 24
$-9.2M
$-40.7M
Q3 24
$-4.1M
$-35.3M
Q2 24
$5.7M
$30.7M
Q1 24
$19.2M
$-15.4M
Free Cash Flow
LSAK
LSAK
TLRY
TLRY
Q4 25
$-14.8M
Q3 25
$4.9M
Q2 25
$-13.2M
$-19.1M
Q1 25
$7.8M
$-20.2M
Q4 24
$-15.5M
$-46.2M
Q3 24
$-8.1M
$-42.0M
Q2 24
$937.0K
$21.0M
Q1 24
$16.2M
$-24.9M
FCF Margin
LSAK
LSAK
TLRY
TLRY
Q4 25
-8.3%
Q3 25
2.9%
Q2 25
-7.8%
-8.5%
Q1 25
4.9%
-10.9%
Q4 24
-8.8%
-21.9%
Q3 24
-5.3%
-21.0%
Q2 24
0.6%
9.1%
Q1 24
11.7%
-13.2%
Capex Intensity
LSAK
LSAK
TLRY
TLRY
Q4 25
2.2%
Q3 25
2.3%
Q2 25
2.4%
2.8%
Q1 25
1.7%
7.8%
Q4 24
3.6%
2.6%
Q3 24
2.6%
3.4%
Q2 24
3.2%
4.2%
Q1 24
2.1%
5.1%
Cash Conversion
LSAK
LSAK
TLRY
TLRY
Q4 25
-2.99×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LSAK
LSAK

Telecom Products And Services$82.0M46%
Processing Fees$37.6M21%
Enterprise Segment$14.5M8%
Rest Of Africa$10.9M6%
Technology Products$8.6M5%
Insurance Revenue$7.9M4%
Lending Revenue$7.2M4%
Other$6.7M4%
Interest From Customer$2.1M1%
Other Products And Services$1.2M1%

TLRY
TLRY

Adultuse Cannabis Products$62.4M29%
Other$59.2M27%
Beverage Alcohol Business$53.6M25%
International Cannabis Products$20.2M9%
Wellness Business$14.6M7%
Medical Cannabis Products$6.2M3%
Wholesale Cannabis Products$1.3M1%

Related Comparisons